Amplifon consensus in focus, analysts see stable hearing care shares

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-29, 10:17.

Amplifon (IT0004056880) sits in the FTSE MIB on Borsa Italiana and remains a regular subject of analyst coverage in European healthcare and consumer reports. The current focus is on the consensus view for the hearing care specialist, as compiled by several research houses and data providers.

What analysts currently say

Analyst data providers such as MarketScreener and other consensus platforms show that Amplifon is followed by a double-digit number of analysts, with a majority of them assigning positive ratings on the shares. The group is commonly classified in the healthcare and consumer services sector, reflecting its mix of medical devices and retail distribution.

Recent broker commentary from houses including Goldman Sachs and UBS has highlighted Amplifon’s positioning in the global hearing care market and its exposure to aging populations, disposable income and private-pay healthcare trends. These notes typically emphasize the company’s store network scale, recurring customer relationships and brand recognition in key European markets.

How consensus frames the outlook

Consensus figures published by data aggregators show expectations for continued revenue growth at Amplifon, driven by network expansion and steady same-store sales. EBITDA margin projections by analysts tend to reflect operational leverage, with efficiency gains in the store base offsetting investments in digital tools and marketing.

Several research houses mention Amplifon alongside peers such as Demant, GN Store Nord and Sonova when comparing valuation multiples and growth profiles. In these sector comparisons, Amplifon is often noted for its strong presence in Italy and broader Europe, while Nordic peers typically have a larger manufacturing footprint. The consensus narrative therefore places Amplifon as a key listed pure-play on retail audiology services.

What the company sells

Amplifon’s core business is retail hearing care, with a global network of stores and clinics providing hearing tests, fitting services and ongoing support. The company sells and services hearing aids and related accessories for consumers, focusing on personalized solutions and long-term customer relationships.

Where the stock trades today

The Amplifon shares (IT0004056880) trade on Borsa Italiana in Milan, with the last verified closing price available from exchange data providers, quoted in euros.

Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any transaction. All data are based on publicly available sources and may be subject to change.